Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain
Open Access
- 26 January 2009
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 206 (2) , 463-475
- https://doi.org/10.1084/jem.20082487
Abstract
Adoptive transfer of T lymphocytes transduced with a T cell receptor (TCR) to impart tumor reactivity has been reported as a potential strategy to redirect immune responses to target cancer cells (Schumacher, T.N. 2002. Nat. Rev. Immunol. 2:512–519). However, the affinity of most TCRs specific for shared tumor antigens that can be isolated is usually low. Thus, strategies to increase the affinity of TCRs or the functional avidity of TCR-transduced T cells might be therapeutically beneficial. Because glycosylation affects the flexibility, movement, and interactions of surface molecules, we tested if selectively removing conserved N-glycoslyation sites in the constant regions of TCR α or β chains could increase the functional avidity of T cells transduced with such modified TCRs. We observed enhanced functional avidity and improved recognition of tumor cells by T cells harboring TCR chains with reduced N-glycosylation (ΔTCR) as compared with T cells with wild-type (WT) TCR chains. T cells transduced with WT or ΔTCR chains bound tetramer equivalently at 4°C, but tetramer binding was enhanced at 37°C, predominantly as a result of reduced tetramer dissociation. This suggested a temperature-dependent mechanism such as TCR movement in the cell surface or structural changes of the TCR allowing improved multimerization. This strategy was effective with mouse and human TCRs specific for different antigens and, thus, should be readily translated to TCRs with any specificity.Keywords
This publication has 56 references indexed in Scilit:
- Facilitating matched pairing and expression of TCR chains introduced into human T cellsBlood, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 StabilityCancer Research, 2006
- Sialylation regulates peripheral tolerance in CD4+ T cellsInternational Immunology, 2005
- Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivoCell Death & Differentiation, 2005
- Age‐related defects in CD4+ T cell activation reversed by glycoprotein endopeptidaseEuropean Journal of Immunology, 2003
- TCRs with high affinity for foreign pMHC show self-reactivityNature Immunology, 2002
- Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not manGene Therapy, 2002
- Roles for glycosylation of cell surface receptors involved in cellular immune recognitionJournal of Molecular Biology, 1999
- A TCR Binds to Antagonist Ligands with Lower Affinities and Faster Dissociation Rates Than to AgonistsImmunity, 1996